Physician profile
Ron Arison
NPI 1366406563
$841.95
in general payments reported to CMS, 2019-2025
19 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $32.71 · 2021: $75.21 · 2022: $252 · 2023: $16.89 · 2024: $119 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $155.69 | 2022-2024 | |
| Organogenesis INC. | $154.79 | 2019-2025 | Apligraf, Puraply Wound Matrix, Puraply |
| Integra Lifesciences Corporation | $69.99 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $53.80 | 2019-2024 | Nuzyra |
| Kerecis Limited | $49.58 | 2022 | |
| Molnlycke Health Care US, LLC | $46.18 | 2025 | Mepilex Ag, Exufiber, Mepitel One |
| Davol INC. | $46.12 | 2021 | |
| Smith+Nephew, INC. | $44.61 | 2019-2021 | |
| Tela Bio, INC. | $32.71 | 2020 | |
| Mallinckrodt Enterprises LLC | $27.80 | 2019 | |
| Portola Pharmaceuticals, LLC | $24.87 | 2019 | |
| Artivion, INC. | $22.06 | 2019 | |
| Innocoll Pharmaceuticals Limited | $19.93 | 2022 | |
| Tei Medical INC. | $18.87 | 2019 | |
| Melinta Therapeutics, LLC | $17.95 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $17.41 | 2022 | |
| Solventum Corporation | $13.50 | 2024 | 3m Coban, Activ.A.C., Adaptic |
| Tactile Systems Technology INC | $13.09 | 2024 | Entre Plus, Flexitouch Plus |
| Bioventus LLC | $13.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Arison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.